{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:59:37Z","timestamp":1765357177336,"version":"3.41.2"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T00:00:00Z","timestamp":1657411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22133008","JP13398866","JP13380361","JP23689022","19H03588","21K07534"],"award-info":[{"award-number":["JP22133008","JP13398866","JP13380361","JP23689022","19H03588","21K07534"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mitsui Life Social Welfare Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Study Objectives<\/jats:title>\n                  <jats:p>Narcolepsy type 1 (NT1) is associated with metabolic abnormalities but their etiology remains largely unknown. The gene for carnitine palmitoyltransferase 1B (CPT1B) and abnormally low serum acylcarnitine levels have been linked to NT1. To elucidate the details of altered fatty acid metabolism, we determined levels of individual acylcarnitines and evaluated CPT1 activity in patients with NT1 and other hypersomnia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Blood samples from 57 NT1, 51 other hypersomnia patients, and 61 healthy controls were analyzed. The levels of 25 major individual acylcarnitines were determined and the C0\/(t[C16] + t[C18]) ratio was used as a CPT1 activity marker. We further performed transcriptome analysis using independent blood samples from 42 NT1 and 42 healthy controls to study the relevance of fatty acid metabolism. NT1-specific changes in CPT1 activity and in expression of related genes were investigated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CPT1 activity was lower in patients with NT1 (p = 0.00064) and other hypersomnia (p = 0.0014) than in controls. Regression analysis revealed that CPT1 activity was an independent risk factor for NT1 (OR: 1.68; p = 0.0031) and for other hypersomnia (OR: 1.64; p = 0.0042). There was a significant interaction between obesity (BMI &amp;lt;25, \u226525) and the SNP rs5770917 status such that nonobese NT1 patients without risk allele had better CPT1 activity (p = 0.0089). The expression levels of carnitine-acylcarnitine translocase (CACT) and CPT2 in carnitine shuttle were lower in NT1 (p = 0.000051 and p = 0.00014, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results provide evidences that abnormal fatty acid metabolism is involved in the pathophysiology of NT1 and other hypersomnia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/sleep\/zsac160","type":"journal-article","created":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T15:16:46Z","timestamp":1657466206000},"source":"Crossref","is-referenced-by-count":8,"title":["Low carnitine palmitoyltransferase 1 activity is a risk factor for narcolepsy type 1 and other hypersomnia"],"prefix":"10.1093","volume":"45","author":[{"given":"Makoto","family":"Honda","sequence":"first","affiliation":[{"name":"Sleep Disorders Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science , Tokyo , Japan"},{"name":"Japan Somnology Center and Seiwa Hospital, Institute of Neuropsychiatry , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Shigematsu","sequence":"additional","affiliation":[{"name":"Department of Health Science, Faculty of Medical Sciences, University of Fukui , Fukui , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Shimada","sequence":"additional","affiliation":[{"name":"Sleep Disorders Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science , Tokyo , Japan"},{"name":"Department of Human Genetics, Graduate School of Medicine, The University of Tokyo , Tokyo , Japan"},{"name":"Genome Medical Science Project (Toyama), National Center for Global Health and Medicine , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Honda","sequence":"additional","affiliation":[{"name":"Sleep Disorders Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushi","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Graduate School of Medicine, The University of Tokyo , Tokyo , Japan"},{"name":"Genome Medical Science Project (Toyama), National Center for Global Health and Medicine , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-9420","authenticated-orcid":false,"given":"Taku","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Sleep Disorders Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science , Tokyo , Japan"},{"name":"Department of Human Genetics, Graduate School of Medicine, The University of Tokyo , Tokyo , Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,7,10]]},"reference":[{"issue":"6","key":"2022101005265348400_CIT0001","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2010.11.032","article-title":"Sleep state switching","volume":"68","author":"Saper","year":"2010","journal-title":"Neuron."},{"issue":"1","key":"2022101005265348400_CIT0002","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5664\/jcsm.9638","article-title":"Disrupted nighttime sleep and sleep instability in narcolepsy","volume":"18","author":"Maski","year":"2022","journal-title":"J Clin Sleep Med."},{"issue":"12","key":"2022101005265348400_CIT0003","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.5664\/jcsm.6352","article-title":"Growing up with type 1 narcolepsy: its anthropometric and endocrine features","volume":"12","author":"Ponziani","year":"2016","journal-title":"J Clin Sleep Med."},{"issue":"6","key":"2022101005265348400_CIT0004","doi-asserted-by":"crossref","first-page":"835","DOI":"10.5665\/sleep.2706","article-title":"Comorbidity and mortality of narcolepsy: a controlled retro- and prospective national study","volume":"36","author":"Jennum","year":"2013","journal-title":"Sleep."},{"issue":"9","key":"2022101005265348400_CIT0005","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med."},{"issue":"3","key":"2022101005265348400_CIT0006","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron."},{"key":"2022101005265348400_CIT0007","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fnbeh.2013.00028","article-title":"Role of orexin in modulating arousal, feeding, and motivation","volume":"7","author":"Tsujino","year":"2013","journal-title":"Front Behav Neurosci."},{"issue":"Pt 23","key":"2022101005265348400_CIT0008","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1113\/jphysiol.2011.217000","article-title":"Orexin neurons as conditional glucosensors: paradoxical regulation of sugar sensing by intracellular fuels","volume":"589","author":"Venner","year":"2011","journal-title":"J Physiol."},{"key":"2022101005265348400_CIT0009","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/7854_2016_51","article-title":"Roles for orexin\/hypocretin in the control of energy balance and metabolism","volume":"33","author":"Goforth","year":"2017","journal-title":"Curr Top Behav Neurosci."},{"issue":"3","key":"2022101005265348400_CIT0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neulet.2005.01.046","article-title":"Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions","volume":"380","author":"Hara","year":"2005","journal-title":"Neurosci Lett."},{"issue":"6","key":"2022101005265348400_CIT0011","doi-asserted-by":"crossref","first-page":"653","DOI":"10.5664\/jcsm.1474","article-title":"Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy","volume":"7","author":"Heier","year":"2011","journal-title":"J Clin Sleep Med."},{"issue":"11","key":"2022101005265348400_CIT0012","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ng.231","article-title":"Variant between CPT1B and CHKB associated with susceptibility to narcolepsy","volume":"40","author":"Miyagawa","year":"2008","journal-title":"Nat Genet."},{"issue":"3","key":"2022101005265348400_CIT0013","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/sleep\/34.3.349","article-title":"Abnormally low serum acylcarnitine levels in narcolepsy patients","volume":"34","author":"Miyagawa","year":"2011","journal-title":"Sleep."},{"issue":"4","key":"2022101005265348400_CIT0014","doi-asserted-by":"crossref","first-page":"e5394","DOI":"10.1371\/journal.pone.0005394","article-title":"Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia)","volume":"4","author":"Miyagawa","year":"2009","journal-title":"PLoS One."},{"key":"2022101005265348400_CIT0015","volume-title":"International Classification of Sleep Disorders","author":"American Academy of Sleep Medicine","year":"2014","edition":"3"},{"issue":"1","key":"2022101005265348400_CIT0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2009.08.002","article-title":"Energy expenditure and aging","volume":"9","author":"Manini","year":"2010","journal-title":"Ageing Res Rev."},{"issue":"5","key":"2022101005265348400_CIT0017","doi-asserted-by":"crossref","first-page":"E1039","DOI":"10.1152\/ajpendo.2000.279.5.E1039","article-title":"Lipid oxidation is reduced in obese human skeletal muscle","volume":"279","author":"Kim","year":"2000","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"5","key":"2022101005265348400_CIT0018","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.sleep.2008.04.015","article-title":"Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory","volume":"10","author":"Takegami","year":"2009","journal-title":"Sleep Med."},{"issue":"1","key":"2022101005265348400_CIT0019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1570-0232(03)00281-2","article-title":"Selective screening for fatty acid oxidation disorders by tandem mass spectrometry: difficulties in practical discrimination","volume":"792","author":"Shigematsu","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci."},{"issue":"10","key":"2022101005265348400_CIT0020","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/clinchem\/47.10.1763","article-title":"Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific","volume":"47","author":"Fingerhut","year":"2001","journal-title":"Clin Chem."},{"issue":"1","key":"2022101005265348400_CIT0021","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics."},{"issue":"10","key":"2022101005265348400_CIT0022","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/nar\/gks042","article-title":"Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation","volume":"40","author":"McCarthy","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"2022101005265348400_CIT0023","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2022101005265348400_CIT0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang da","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"2022101005265348400_CIT0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc."},{"issue":"6235","key":"2022101005265348400_CIT0026","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1126\/science.aaa0355","article-title":"Human genomics. The human transcriptome across tissues and individuals","volume":"348","author":"Mele","year":"2015","journal-title":"Science."},{"key":"2022101005265348400_CIT0027","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.abb.2015.09.017","article-title":"A single night of sleep curtailment increases plasma acylcarnitines: novel insights in the relationship between sleep and insulin resistance","volume":"589","author":"van den Berg","year":"2016","journal-title":"Arch Biochem Biophys."},{"issue":"9","key":"2022101005265348400_CIT0028","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/oby.2009.510","article-title":"Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity","volume":"18","author":"Mihalik","year":"2010","journal-title":"Obesity (Silver Spring)."},{"issue":"6","key":"2022101005265348400_CIT0029","doi-asserted-by":"crossref","first-page":"e40009","DOI":"10.1371\/journal.pone.0040009","article-title":"Body fat free mass is associated with the serum metabolite profile in a population-based study","volume":"7","author":"Jourdan","year":"2012","journal-title":"PLoS One."},{"issue":"12","key":"2022101005265348400_CIT0030","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s10038-018-0518-8","article-title":"A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia","volume":"63","author":"Miyagawa","year":"2018","journal-title":"J Hum Genet."},{"key":"2022101005265348400_CIT0031","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.7717\/peerj.66","article-title":"Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia","volume":"1","author":"Khor","year":"2013","journal-title":"PeerJ."},{"issue":"9","key":"2022101005265348400_CIT0032","doi-asserted-by":"crossref","first-page":"955","DOI":"10.5664\/jcsm.3004","article-title":"Disrupted nighttime sleep in narcolepsy","volume":"9","author":"Roth","year":"2013","journal-title":"J Clin Sleep Med."},{"key":"2022101005265348400_CIT0033","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-244X-14-204","article-title":"Frequent nocturnal awakening in children: prevalence, risk factors, and associations with subjective sleep perception and daytime sleepiness","volume":"14","author":"Li","year":"2014","journal-title":"BMC Psychiatry."},{"issue":"10","key":"2022101005265348400_CIT0034","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochim Biophys Acta."},{"issue":"Suppl 1","key":"2022101005265348400_CIT0035","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/clinids\/18.Supplement_1.S62","article-title":"Acylcarnitine deficiency in chronic fatigue syndrome","volume":"18","author":"Kuratsune","year":"1994","journal-title":"Clin Infect Dis."},{"issue":"1","key":"2022101005265348400_CIT0036","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2796.2010.02341.x","article-title":"Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity","volume":"270","author":"Reuter","year":"2011","journal-title":"J Intern Med."},{"issue":"11","key":"2022101005265348400_CIT0037","first-page":"1551","article-title":"Sleep-stage dynamics in patients with chronic fatigue syndrome with or without fibromyalgia","volume":"34","author":"Kishi","year":"2011","journal-title":"Sleep."},{"issue":"12","key":"2022101005265348400_CIT0038","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.sleep.2015.06.007","article-title":"Sleep-stage transitions during polysomnographic recordings as diagnostic features of type 1 narcolepsy","volume":"16","author":"Christensen","year":"2015","journal-title":"Sleep Med."},{"issue":"8","key":"2022101005265348400_CIT0039","doi-asserted-by":"crossref","first-page":"885","DOI":"10.5664\/jcsm.4940","article-title":"Altered sleep stage transitions of REM sleep: a novel and stable biomarker of narcolepsy","volume":"11","author":"Liu","year":"2015","journal-title":"J Clin Sleep Med."},{"issue":"8","key":"2022101005265348400_CIT0040","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.5665\/sleep.4908","article-title":"Nocturnal sleep dynamics identify narcolepsy type 1","volume":"38","author":"Pizza","year":"2015","journal-title":"Sleep."},{"key":"2022101005265348400_CIT0041","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.arr.2014.11.001","article-title":"Sleep disorders, obesity, and aging: the role of orexin","volume":"20","author":"Nixon","year":"2015","journal-title":"Ageing Res Rev."},{"issue":"11","key":"2022101005265348400_CIT0042","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/sleep\/29.11.1429","article-title":"A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness","volume":"29","author":"Hong","year":"2006","journal-title":"Sleep."},{"issue":"10","key":"2022101005265348400_CIT0043","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.5665\/sleep.4066","article-title":"HLA DQB1*06:02 negative narcolepsy with hypocretin\/orexin deficiency","volume":"37","author":"Han","year":"2014","journal-title":"Sleep."},{"issue":"1","key":"2022101005265348400_CIT0044","first-page":"22","article-title":"Absorption and excretion of","volume":"63","author":"Baker","year":"1993","journal-title":"Int J Vitam Nutr Res."},{"issue":"9","key":"2022101005265348400_CIT0045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF03261931","article-title":"Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects","volume":"51","author":"Reuter","year":"2012","journal-title":"Clin Pharmacokinet."},{"issue":"1","key":"2022101005265348400_CIT0046","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.plipres.2009.08.004","article-title":"Acylcarnitines: role in brain","volume":"49","author":"Jones","year":"2010","journal-title":"Prog Lipid Res."}],"container-title":["Sleep"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/sleep\/advance-article-pdf\/doi\/10.1093\/sleep\/zsac160\/45317955\/zsac160.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/45\/10\/zsac160\/45986652\/zsac160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/sleep\/article-pdf\/45\/10\/zsac160\/45986652\/zsac160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T12:45:01Z","timestamp":1665405901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/sleep\/article\/doi\/10.1093\/sleep\/zsac160\/6639424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,10]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,7,10]]},"published-print":{"date-parts":[[2022,10,10]]}},"URL":"https:\/\/doi.org\/10.1093\/sleep\/zsac160","relation":{},"ISSN":["0161-8105","1550-9109"],"issn-type":[{"type":"print","value":"0161-8105"},{"type":"electronic","value":"1550-9109"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,7,10]]},"article-number":"zsac160"}}